Novel genetically engineered mouse models for clear cell renal cell carcinoma
Abstract Genetically engineered mouse models (GEMMs) are important immunocompetent models for research into the roles of individual genes in cancer and the development of novel therapies. Here we use inducible CRISPR-Cas9 systems to develop two GEMMs which aim to model the extensive chromosome p3 de...
Main Authors: | Johannes C. van der Mijn, Kristian B. Laursen, Leiping Fu, Francesca Khani, Lukas E. Dow, Dawid G. Nowak, Qiuying Chen, Steven S. Gross, David M. Nanus, Lorraine J. Gudas |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-35106-7 |
Similar Items
-
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma
by: Kristian B. Laursen, et al.
Published: (2021-12-01) -
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma
by: Johannes C. van der Mijn, et al.
Published: (2020-02-01) -
Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.
by: Denise R Minton, et al.
Published: (2015-01-01) -
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma
by: Jaclyn M. Kubala, et al.
Published: (2023-12-01) -
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
by: Johannes C. van derMijn, et al.
Published: (2022-06-01)